Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action

Anneleen Hombrouck(KU Leuven), Myriam Witvrouw(Rega Institute for Medical Research), Jo Vercammen(KU Leuven), Victor Tetz(First Pavlov State Medical University of St. Petersburg), Frauke Christ(KU Leuven), Zeger Debyser(KU Leuven), Yves Engelborghs(KU Leuven), David Rhodes(Purdue University West Lafayette), Anke Hantson(KU Leuven), M Michiels(KU Leuven), Barbara Van Remoortel(KU Leuven)
Journal of Antimicrobial Chemotherapy
April 30, 2007
Cited by 18


Related Papers